Drug Approval | June 13, 2024
Torrent Pharmaceuticals gets Form 483 with 5 observations for Indrad facility
There was no observation related to data integrity reported
There was no observation related to data integrity reported
The primary endpoint in the final analysis was assessed by change in the North Star Ambulatory Assessment at one year after treatment
Glenmark's current portfolio consists of 197 products authorized for distribution in the U.S. marketplace
Nadda also interacted with senior officials of the Union Health Ministry after taking charge where he was briefed about the ongoing projects
Prior to taking charge at the Union Health Ministry, Jadhav planted a sapling at his residence
Abbott's first-of-its-kind i2i technology enables synchronized communication between two leadless pacemakers
The new brand identity embodies Neuland's unwavering commitment to innovation, integrity, collaboration, and progress
his strategic collaboration with BluSim Tech marks a significant milestone in Fischer MVL's journey towards expanding its healthcare portfolio
The Gavi Board today approved the Vaccine Alliance's strategy for the five-year period running from 2026 to 2030
Innovative technologies and comprehensive services to strengthen Syntegon’s strategic growth
Subscribe To Our Newsletter & Stay Updated
